View details of this raise on Seedstage

Mayaguez, PR

Developing advanced superconducting technology to enhance MRI affordability and efficiency.

• Mission: Revolutionizing the MRI industry by developing cryogen-free superconducting technology that significantly reduces scan costs, improving the affordability and accessibility of medical imaging.  
• Innovation: Pioneering the use of MgB2 technology to create more efficient and cost-effective MRI systems, while also addressing the critical helium shortage affecting the medical imaging industry.  
• Market Opportunity: Expanding applications of superconducting technologies across multiple sectors, with the recent discovery of CES-2023, a Room Temperature Ambient Pressure Superconductor, potentially impacting markets worth over $1 trillion.  
• Economic Impact: Contributing to the local economy in Puerto Rico by establishing a state-of-the-art manufacturing facility that will create high-tech job opportunities.  
• Funding Uses: Supporting the expansion of manufacturing capabilities and further development of innovative superconducting technologies to establish CES as a leader in medical imaging and superconductivity.  
• Leadership: Led by Dr. Yong-Jihn Kim, with over 30 years of experience in superconductivity, CES is positioned to revolutionize the industry and aims for an IPO on NASDAQ within the next three years.  

Cutting Edge Superconductors aims to revolutionize the MRI industry through the development of its patented MgB2 technology, which enables cryogen-free 1.5T MRI systems that can reduce scan costs significantly, thereby improving public health services. The company is establishing a manufacturing facility in Puerto Rico to produce MgB2 wires, which is expected to create high-tech job opportunities in the local community. Recently, CES made a groundbreaking discovery of a Room Temperature Ambient Pressure Superconductor, named CES-2023, which holds potential for applications across various sectors, possibly impacting markets worth over $1 trillion.

By collaborating with major MRI and NMR manufacturing companies, CES aims to address the critical helium shortage that has plagued the industry, providing solutions that enhance the efficiency and affordability of medical imaging. This fundraising initiative is intended to support the expansion of their manufacturing capabilities and further development of their innovative superconducting technologies, thereby positioning CES as a leader in the next generation of medical imaging and superconductivity solutions.

Company Info

Cutting Edge Superconductors is revolutionizing superconductivity with patented MgB2 technology and groundbreaking discoveries like CES-2023.

Cutting Edge Superconductors, Inc. (CES) is pioneering advancements in superconductivity through its patented technology for enhanced magnesium diboride (MgB2) wires. CES is focused on revolutionizing critical equipment like MRI scanners, wind turbines, and superconducting energy storage systems with its cryogen-free solutions. Headquartered in Puerto Rico, CES is also contributing to the local economy by creating hundreds of high-tech jobs through its state-of-the-art manufacturing facility. The company has garnered support from key institutions like the National Science Foundation and the Puerto Rico Science Trust to scale its operations and bring its technology to the market.

Led by Dr. Yong-Jihn Kim, who has over 30 years of expertise in superconductivity, CES recently achieved a breakthrough with the discovery of CES-2023, a Room Temperature Ambient Pressure Superconductor. This groundbreaking discovery has the potential to reshape global markets valued at over $5 trillion. The company is committed to building on this success and aims for a public offering (IPO) on NASDAQ within the next three years, positioning itself as a leader in the superconducting technology landscape.